-
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution
23 Apr 2024 11:30 GMT
… Food and Drug Administration (FDA) for … your doctor right away. Treatment with … medicines that block tumor necrosis factor, such as Enbrel® (etanercept), Humira® (adalimumab …
KINIKSA PHARMACEUTICALS, LTD.
CONSOLIDATED STATEMENTS OF OPERATIONS …
-
AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
22 Apr 2024 18:20 GMT
… Francisco, California/iStock, vzphotos
Doctors overwhelmingly consider AbbVie as the … bolstered by its top-selling drugs Humira (adalimumab) and Skyrizi (risankizumab), according … 7 billion acquisition of Arena Pharmaceuticals, Pfizer jumped three spots up …
-
Samsung Bioepis Initiates Phase 3 Clinical Trial for Proposed Pembrolizumab Biosimilar
22 Apr 2024 16:51 GMT
… trials for SB27.”1
The phase 3 clinical trial … NSCLC). Investigators will randomize treatment 1:1 for SB27 … and United States-sourced drugs, according to an … including for etanercept, infliximab, adalimumab, trastuzumab, bevacizumab, ranibizumab, eculizumab …
-
Biosimilar Sales Up as Insurers Begin Dropping Humira Coverage
24 Apr 2024 09:43 GMT
… AbbVie building and pill bottles/Taylor … for its flagship drug Humira (adalimumab). But for the … other large pharmaceutical companies because its biggest drug is … established relationship with various Medicaid/Medicare agencies and commercial insurers …
-
Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review
20 Apr 2024 12:31 GMT
… agents (eg infliximab and adalimumab, golimumab, vedolizumab, ustekinumab … there are limited pharmaceuticals available, particularly … whilst pill counts assess how many pills patients … their prescribed medication in improving treatment adherence in …
-
Stelara Biosimilar Ustekinumab-aekn Recieves FDA Approval
19 Apr 2024 20:21 GMT
… in the treatment of immune mediated diseases.
FDA approval was … development program for the drug included data from 2 … the first approval was adalimumab biosimilar AVT02 (Simlandi), … tenth biosimilar product referencing adalimumab (Humira).
Sales of reference …
-
Strategies to Increase Adalimumab Biosimilar Uptake in Clinical Practice
19 Apr 2024 17:56 GMT
-
Selecting Between Adalimumab Biosimilars for Your Patients
19 Apr 2024 17:56 GMT
-
Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
19 Apr 2024 10:10 GMT
… biotech company specializing in the development and manufacture of biosimilar medicines … U.S. Food and Drug Administration (FDA) approved high-concentration … Pharmaceuticals and Alvotech remains unchanged and Teva will continue to commercialize adalimumab …
-
Alvotech Signs U.S. Agreement
23 Apr 2024 09:13 GMT
… biotech company specialising in the development and manufacture of biosimilar medicines … U.S. Food and Drug Administration (FDA) approved high-concentration … Pharmaceuticals and Alvotech remains unchanged and Teva will continue to commercialise adalimumab …